← All trials
NCT01866397
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2002
- Primary completion
- Mar 31, 2002
- Completion date
- Mar 31, 2002
- First posted
- May 31, 2013
- Last posted
- Jun 5, 2013
- Enrollment
- 1
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Medical University of ViennaLead sponsor
- Medical University of ViennaOverall official - principal investigator
- Medical University of ViennaReponsible party - principal investigator
- University of ViennaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.